
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
The FDA is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.

Pharma Tech
The biotechâs potential launch on the public markets would help fuel development of its clinical-stage, melanocortin-focused pipeline.

Pharma Tech
Vivaniâs NanoPortal technology delivers medication steadily over long periods of time.

Pharma Tech
The US FDA has granted rare paediatric disease designation to Vanda Pharmaceuticalsâ VCA-894A, an investigational antisense oligonucleotide therapy for CMT2S.

Pharma Tech
Biocytogen and Whitehawk Therapeutics are set to develop bispecific antibody-drug conjugates (BsADCs), as part of a global partnership.
Sponsored content

Purchase All Medicines.Get 10% Offer
News
Pharma Tech
Jul 8, 2026, 2:10 PM
The FDA is taking action to curb the illicit online trade of unregulated and unapproved ketamine products through a slew of warning letters.
PharmaShots
Jul 8, 2026, 12:30 PM
Shots: Ref: Businesswire  |  Image: Immunome |Press Release Related News: Immunome Reports the US FDAâs NDA Submission for Varegacestat to Treat Desmoid Tumors in Adults PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Immunome Reports the US FDAâs NDA Acceptance of Varegacestat to Treat Desmoid Tumors in Adults appeared first on PharmaShots.
ET Pharma
Jul 8, 2026, 12:29 PM
The Chinese drugmaker is eligible to receive an upfront payment of $200 million, âwith additional development, regulatory and sales milestones, totalling up to $1.9 âbillion.
ET Pharma
Jul 8, 2026, 12:25 PM
The company has entered into a definitive agreement to acquire 100 per cent of the share capital of ABCnow GmbH for euro 8,92,384 (nearly Rs 10 crore).
ET Pharma
Jul 8, 2026, 12:13 PM
The domestic market sales tracker, PharmaTrac, in its latest reporting cycle âJuneâ sharply upgraded its 2026 growth forecast to 11.3 per cent from an earlier estimate of 8.1 per cent, citing stronger-than-expected trends in the first half of the year.
PharmaShots
Jul 8, 2026, 11:30 AM
Shots: Ref: PRnewswire  |  Image:  Insilico Medicine  | Press Release Related News: Insilico Medicine Collaborates with Takeda to Advance AI Drug Discovery PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Insilico Medicine Advances AI-Designed IPF Drug Rentosertib into P-III Trial appeared first on PharmaShots.
News
Google News
Jul 8, 2026, 4:46 PM
In private meeting, Trump officials push to onshore generic drugmaking  STAT
Google News
Jul 8, 2026, 4:18 PM
Ciro Pharma invests Rs 800 Cr to open Indiaâs first integrated oncology manufacturing facility in Hyderabad  BioSpectrum India
Google News
Jul 8, 2026, 4:05 PM
AstraZeneca, GSK intensify China ties with Sino Biopharm deals  BioPharma Dive
Google News
Jul 8, 2026, 4:02 PM
Wall Street Is Betting on Eli Lillyâs GLP-1 Portfolio â Itâs Missing the $1 Trillion Opportunity  24/7 Wall St.
Google News
Jul 8, 2026, 3:59 PM
OTR Therapeutics, LG Chem Partner to Accelerate Novel Oncology Therapy Development  Contract Pharma
Google News
Jul 8, 2026, 3:31 PM
Foreign drugmaker caught faking doctorsâ petition to evade Chinaâs price cut scheme  Fierce Pharma
Google News
Jul 8, 2026, 3:15 PM
FUJIFILM Biotechnologies Selected in FDA PreCheck Pilot Program to Advance U.S. Drug Manufacturing  BioSpace
Google News
Jul 8, 2026, 3:02 PM
Fujifilm Holly Springs Selected for FDA PreCheck Pilot  Contract Pharma
Google News
Jul 8, 2026, 2:53 PM
Government approves pharmaceutical policy to boost local drug production  Modern Ghana
Sponsored placement

Purchase All Medicines.Get 10% Offer